Kyrah Tablet contains Ethinyl Estradiol (0.03 mg) and Desogestrel (0.15 mg), a combination of synthetic estrogen and progestin used primarily for oral contraception. This medication works by inhibiting ovulation, altering the cervical mucus to prevent sperm penetration, and modifying the endometrial lining to reduce the likelihood of implantation. Kyrah Tablet is indicated for the prevention of pregnancy in women seeking reliable birth control. It is essential to take the tablet daily at the same time to maintain effective hormone levels and minimize the risk of unintended pregnancy. Prior to initiating therapy, a thorough medical history and assessment of contraindications, such as thromboembolic disorders, hormone-sensitive malignancies, or liver disease, should be conducted. Common side effects may include nausea, headache, breast tenderness, and breakthrough bleeding, which often resolve with continued use. Patients should be advised to report any signs of serious adverse effects such as severe abdominal pain, chest pain, sudden vision changes, or leg swelling, as these may indicate thromboembolic events. Kyrah Tablet does not protect against sexually transmitted infections. Use of this medication should be under the guidance of a healthcare professional, with regular follow-up to monitor efficacy and safety.